By Justin Petrone

Royal Philips Electronics and bioMérieux plan to jointly develop fully automated handheld diagnostic biochips for hospital use that can be deployed at the point of care. The firms are aiming for eventual adoption of their chips in critical care settings within hospitals.

The deal is the latest for Philips, which is increasingly looking for partners to bring applications to market on its internally developed biosensor and microarray platforms.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.